VA Boston Healthcare System, Boston, Massachusetts, USA
VA Bedford Healthcare System, Bedford, Massachusetts, USA, Bedford, MA, USA.
BMJ Open. 2024 Feb 28;14(2):e080338. doi: 10.1136/bmjopen-2023-080338.
Pharmacists provide a spectrum of services and comprehensive medication management for patients with substance use disorders (SUDs) with many providing timely and increased access to care for patients. Prior studies have evaluated other healthcare professionals' attitudes, knowledge and practice in regard to SUD treatment and harm reduction services. However, no reviews to date summarise the available literature on the attitudes, knowledge and practice in regard to SUD treatment and harm reduction services from the pharmacist perspective. This scoping review aims to systematically map the extent, range and nature of available evidence and identify and describe gaps in knowledge, practice and attitudes towards SUD treatment among pharmacists with the goal of providing information for meaningful integration of pharmacists into SUD care.
We will use the framework proposed by Arksey and O'Malley (2005) updated with recommendations by Levac (2010) and the Joanna Briggs Institute (2020). The protocol is registered via Open Science Framework (https://osf.io/92dek). We will search for peer-reviewed literature containing empirical evidence investigating SUD treatment or harm reduction with outcomes pertaining to the knowledge, practice or attitudes of pharmacists. Findings will be guided and assessed by research objectives and summarised using descriptive statistics and thematically for quantitative and qualitative findings, respectively. This review will be conducted and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews.
Our findings will provide crucial information and support for future interventions and programmes which aim to meaningfully integrate pharmacists into SUD care. We will disseminate findings at conferences and publish in a peer-reviewed journal. In addition, we will integrate feedback on search strategy, data extraction and our dissemination approach from multidisciplinary collaborators including those within our team's institution and outside experts with clinical or administrative knowledge in SUD care.
药剂师为患有物质使用障碍(SUD)的患者提供一系列服务和全面的药物管理,为患者提供及时和更多的护理机会。先前的研究评估了其他医疗保健专业人员在 SUD 治疗和减少伤害服务方面的态度、知识和实践。然而,迄今为止,没有评论总结药剂师对 SUD 治疗和减少伤害服务的态度、知识和实践的现有文献。本范围综述旨在系统地绘制现有文献的广度、范围和性质,并确定和描述药剂师在 SUD 治疗方面的知识、实践和态度方面的差距,目的是为药剂师有效纳入 SUD 护理提供信息。
我们将使用 Arksey 和 O'Malley(2005 年)提出的框架,并结合 Levac(2010 年)和 Joanna Briggs 研究所(2020 年)的建议进行更新。该方案已在开放科学框架(https://osf.io/92dek)上注册。我们将搜索包含调查 SUD 治疗或减少伤害的实证证据的同行评审文献,其结果与药剂师的知识、实践或态度有关。研究结果将由研究目标指导和评估,并使用描述性统计数据和主题分析分别对定量和定性结果进行总结。本综述将按照系统评价和荟萃分析的首选报告项目进行,并针对范围综述进行报告。
我们的研究结果将为未来的干预措施和计划提供重要信息和支持,这些措施和计划旨在将药剂师有效地纳入 SUD 护理。我们将在会议上发表研究结果,并在同行评议的期刊上发表。此外,我们将整合来自多学科合作者的反馈,包括我们团队内部和具有 SUD 护理临床或管理知识的外部专家,对搜索策略、数据提取和我们的传播方法提出反馈。